ORLANDO — Genetic testing is warranted in patients with epilepsy of unknown origin, new research suggests. Investigators found that pathogenic genetic variants were identified in over 40% of patients ...

Please provide your email address to receive an email when new articles are posted on . The study included 250 patients with epilepsy. A history of delayed development and earlier seizure onset were ...

Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham Heart Study show those who scored ...

STAMFORD, Conn.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...

Please provide your email address to receive an email when new articles are posted on . A limited understanding of non-European DNA may hinder genetic testing interpretations, leading to disparities ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...

The University of Utah College of Pharmacy's Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health (NIH) to ...

Under the initiative, AIIMS will offer monitoring for commonly used anti-epileptic drugs such as phenobarbitone, ...

India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy, the ...

In major relief for epilepsy patients, AIIMS New Delhi began providing free Therapeutic Drug Monitoring (TDM) from January 1 ...